Rafferty Asset Management’s 89bio ETNB Stock Holding History

Rafferty Asset Management’s Portfolio ETNB Stock Details ETNB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q4	–	Sell	-189,837	Closed	-$2.79M	–	1146
2025 Q3	$2.79M	Buy	189,837 +67,484	+55%	+$688K	0.01%	565
2025 Q2	$1.2M	Sell	122,353 -14,894	-11%	-$123K	﹤0.01%	728
2025 Q1	$998K	Buy	137,247 +48,502	+55%	+$424K	﹤0.01%	741
2024 Q4	$694K	Sell	88,745 -38,636	-30%	-$318K	﹤0.01%	858
2024 Q3	$943K	Sell	127,381 -16,147	-11%	-$136K	﹤0.01%	811
2024 Q2	$1.15M	Sell	143,528 -318,424	-69%	-$2.84M	﹤0.01%	786
2024 Q1	$5.38M	Buy	461,952 +8,278	+2%	+$91.6K	0.02%	461
2023 Q4	$5.07M	Buy	453,674 +71,729	+19%	+$659K	0.02%	443
2023 Q3	$5.9M	Sell	381,945 -19,906	-5%	-$334K	0.03%	354
2023 Q2	$7.62M	Buy	401,851 +82,353	+26%	+$1.45M	0.04%	305
2023 Q1	$4.87M	Buy	+319,498	New	+$4.17M	0.03%	390

Other funds holding ETNB

DekaBank Deutsche Girozentrale Frankfurt, Germany $60.6B AUM 23.27% 1-Year Est. Return

IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

Rafferty Asset Management's ETNB Position: Q4 2025 in Review

Rafferty Asset Management sold out of 89bio (ETNB) in Q4 2025, closing a stake of 189,837 shares — an estimated $2.79M sold.

Rafferty Asset Management first reported a position in ETNB in Q1 2023 and held it in 11 quarters. The position peaked at $7.62M in Q2 2023. 2 funds tracked by Wall St. Rank hold ETNB as of Q4 2025.

Rafferty Asset Management reported no remaining 89bio position as of Q4 2025 after selling out during the quarter.
Rafferty Asset Management sold 189,837 89bio shares in Q4 2025, an estimated $2.79M.
Rafferty Asset Management first reported a position in 89bio in Q1 2023 and held it in 11 quarters.
Rafferty Asset Management's 89bio position peaked at $7.62M in Q2 2023.
2 funds tracked by Wall St. Rank held 89bio as of Q4 2025.

Based on Rafferty Asset Management's 13F filing for Q4 2025, filed 13 Feb 2026.